Clinical trial of a drug for loose motion

Phase 2 clinical trial for assessment of safety and efficacy of a multi component botanical therapeutic (SKBDEVI) in patients suffering from gastrointestinal disorders

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/12/010786

Enrollment

300

Registered

2017-12-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients suffering from gastrointestinal disorders such as diarrhea, gastritis, acidity, heartburn, flatulence, bloating, stomach pain, cramps etc.

Interventions

Intervention1: SKBDEVI: Dose: 500 Mgs capsules Frequency: Every 3-4 Hours Route of administration: Oral Duration of therapy: 1-4 weeks Control Intervention1: Placebo: Dose: 500 Mgs capsules Frequency:

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from gastrointestinal disorders such as diarrhea, gastritis, acidity, heartburn, flatulence, bloating, stomach pain, cramps etc.

Exclusion criteria

Exclusion criteria: Patients not suffering from gastrointestinal disorders such as diarrhea, gastritis, acidity, heartburn, flatulence, bloating, stomach pain, cramps etc.

Design outcomes

Primary

Measure	Time frame
Complete freedom from gastrointestinal disorders such as diarrhea, gastritis, acidity, heartburn, flatulence, bloating, stomach pain, cramps etc.Timepoint: 1 day	—

Secondary

Measure	Time frame
Complete freedom from gastrointestinal disorders such as diarrhea, gastritis, acidity, heartburn, flatulence, bloating, stomach pain, cramps etc.Timepoint: 2 weeks	—

Countries

India

Contacts

Public ContactAshok Kumar

SK Biotherapeutics Pvt. Ltd. (Previously SK Biolabs)

ashok846@gmail.com8126688922

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026